Bioqual Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Bioqual's earnings have been declining at an average annual rate of -28.3%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 6.7% per year.
Belangrijke informatie
-28.3%
Groei van de winst
-28.4%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 21.5% |
| Inkomstengroei | 6.7% |
| Rendement op eigen vermogen | -3.0% |
| Nettomarge | -2.0% |
| Laatste winstupdate | 31 Aug 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Bioqual geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Aug 24 | 55 | -1 | 0 | 0 |
| 31 May 24 | 59 | 0 | 0 | 0 |
| 29 Feb 24 | 61 | 0 | 8 | 0 |
| 30 Nov 23 | 62 | 0 | 12 | 0 |
| 31 Aug 23 | 62 | 0 | 12 | 0 |
| 31 May 23 | 63 | 1 | 12 | 0 |
| 28 Feb 23 | 65 | 3 | 11 | 0 |
| 30 Nov 22 | 68 | 5 | 11 | 0 |
| 31 Aug 22 | 66 | 5 | 10 | 0 |
| 31 May 22 | 66 | 5 | 10 | 0 |
| 28 Feb 22 | 64 | 5 | 10 | 0 |
| 30 Nov 21 | 60 | 6 | 10 | 0 |
| 31 Aug 21 | 58 | 6 | 10 | 0 |
| 31 May 21 | 58 | 6 | 9 | 0 |
| 28 Feb 21 | 55 | 5 | 9 | 0 |
| 30 Nov 20 | 54 | 5 | 8 | 0 |
| 31 Aug 20 | 51 | 5 | 8 | 0 |
| 31 May 20 | 46 | 4 | 8 | 0 |
| 29 Feb 20 | 44 | 4 | 7 | 0 |
| 30 Nov 19 | 43 | 4 | 7 | 0 |
| 31 Aug 19 | 40 | 4 | 7 | 0 |
| 31 May 19 | 39 | 3 | 7 | 0 |
| 28 Feb 19 | 38 | 3 | 4 | 0 |
| 30 Nov 18 | 36 | 3 | 4 | 0 |
| 31 Aug 18 | 37 | 4 | 4 | 0 |
| 31 May 18 | 36 | 4 | 3 | 0 |
| 28 Feb 18 | 35 | 3 | 3 | 0 |
| 30 Nov 17 | 36 | 3 | 3 | 0 |
| 31 Aug 17 | 36 | 4 | 3 | 0 |
| 31 May 17 | 37 | 4 | 3 | 0 |
| 28 Feb 17 | 37 | 4 | 3 | 0 |
| 30 Nov 16 | 37 | 4 | 3 | 0 |
| 31 Aug 16 | 36 | 4 | 3 | 0 |
| 31 May 16 | 33 | 3 | 3 | 0 |
| 29 Feb 16 | 31 | 2 | 3 | 0 |
| 30 Nov 15 | 29 | 2 | 3 | 0 |
| 31 Aug 15 | 29 | 2 | 3 | 0 |
| 31 May 15 | 29 | 2 | 3 | 0 |
| 28 Feb 15 | 29 | 2 | 3 | 0 |
| 30 Nov 14 | 26 | 1 | 3 | 0 |
| 31 Aug 14 | 23 | 1 | 3 | 0 |
| 31 May 14 | 22 | 1 | 3 | 0 |
| 28 Feb 14 | 19 | 1 | 3 | 0 |
| 30 Nov 13 | 19 | 0 | 3 | 0 |
Kwaliteitswinsten: BIOQ is currently unprofitable.
Groeiende winstmarge: BIOQ is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: BIOQ is unprofitable, and losses have increased over the past 5 years at a rate of 28.3% per year.
Versnelling van de groei: Unable to compare BIOQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: BIOQ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-10.7%).
Rendement op eigen vermogen
Hoge ROE: BIOQ has a negative Return on Equity (-2.95%), as it is currently unprofitable.